Literature DB >> 23389875

Pain mechanisms in patients with chronic pain.

Diego Fornasari1.   

Abstract

The mechanisms involved in the development of chronic pain are varied and complex. Pain processes are plastic and unrelieved pain may lead to changes in the neural structure involved in pain generation. Nociceptive pain announces the presence of a potentially damaging stimulus that occurs when noxious stimuli activate primary afferent neurons. Neuropathic pain is initiated or caused by a primary lesion or dysfunction in the nervous system resulting from trauma, infection, ischaemia, cancer or other causes such as chemotherapy. The exact mechanisms involved in the pathophysiology of chronic pain are not well understood, but rapid and long-term changes are thought to occur in parts of the central nervous system that are involved in the transmission and modulation of pain following injury. Peripheral and central sensitization of sensory nerve fibres are the primary reasons for hypersensitivity to pain after injury, and mainly occur in inflammatory and neuropathic pain. During these processes the sensation of pain is enhanced as a result of changes in the environment, the nerve fibres and modifications of the functional properties and the genetic programme of primary and secondary afferent neurons. Non-steroidal anti-inflammatory drugs and opioid analgesics are two of the most common classes of drugs used for the treatment of pain. Response to drug treatment shows significant interindividual variability and can lead to side effects. The neurobiological mechanisms that cause pain may account for the different types of pain observed. Identification of these mechanisms may allow us to move from an empirical therapeutic approach to one that it is specifically targeted at the particular mechanisms of the type of pain experienced by an individual patient.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23389875     DOI: 10.2165/11630070-000000000-00000

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN: 1173-2563            Impact factor:   2.859


  7 in total

Review 1.  Interventional Treatment Modalities for Chronic Abdominal and Pelvic Visceral Pain.

Authors:  Christopher Wie; Shirin Ghanavatian; Scott Pew; Alexander Kim; Natalie Strand; John Freeman; Mostafa Maita; Stephen Covington; Jillian Maloney
Journal:  Curr Pain Headache Rep       Date:  2022-07-05

2.  Virus Infections Incite Pain Hypersensitivity by Inducing Indoleamine 2,3 Dioxygenase.

Authors:  Lei Huang; Rong Ou; Guilherme Rabelo de Souza; Thiago M Cunha; Henrique Lemos; Eslam Mohamed; Lingqian Li; Gabriela Pacholczyk; Janice Randall; David H Munn; Andrew L Mellor
Journal:  PLoS Pathog       Date:  2016-05-11       Impact factor: 6.823

3.  A Novel Brucine Gel Transdermal Delivery System Designed for Anti-Inflammatory and Analgesic Activities.

Authors:  Ping Wu; Qin Liang; Pei Feng; Chunyan Li; Chunguang Yang; Hongsuo Liang; Huaibo Tang; Cijun Shuai
Journal:  Int J Mol Sci       Date:  2017-04-03       Impact factor: 5.923

4.  Attenuation of the Diffuse Noxious Inhibitory Controls in Chronic Joint Inflammatory Pain Is Accompanied by Anxiodepressive-Like Behaviors and Impairment of the Descending Noradrenergic Modulation.

Authors:  Raquel Pereira-Silva; José Tiago Costa-Pereira; Raquel Alonso; Paula Serrão; Isabel Martins; Fani L Neto
Journal:  Int J Mol Sci       Date:  2020-04-23       Impact factor: 5.923

5.  Brain-based measures of nociception during general anesthesia with remifentanil: A randomized controlled trial.

Authors:  Keerthana Deepti Karunakaran; Barry D Kussman; Ke Peng; Lino Becerra; Robert Labadie; Rachel Bernier; Delany Berry; Stephen Green; David Zurakowski; Mark E Alexander; David Borsook
Journal:  PLoS Med       Date:  2022-04-22       Impact factor: 11.613

6.  Effectiveness of pulsed radiofrequency on the medial cervical branches for cervical facet joint pain.

Authors:  Min Cheol Chang; Seoyon Yang
Journal:  World J Clin Cases       Date:  2022-08-06       Impact factor: 1.534

7.  Transcutaneous electrical nerve stimulation attenuates CFA-induced hyperalgesia and inhibits spinal ERK1/2-COX-2 pathway activation in rats.

Authors:  Jun-Fan Fang; Yi Liang; Jun-Ying Du; Jian-Qiao Fang
Journal:  BMC Complement Altern Med       Date:  2013-06-15       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.